NIA_Improving Function and Well-being by Improving Patient Memory: Transdiagnostic Sleep and Circadian Treatment
Launched by UNIVERSITY OF CALIFORNIA, BERKELEY · Aug 2, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The clinical trial titled "Improving Function and Well-being by Improving Patient Memory" is studying a new approach to help improve sleep and memory in individuals aged 50 and older who face challenges related to sleep disorders and memory issues. The researchers want to see if a special program called the Memory Support Intervention (MSI) can enhance sleep quality, support daily functioning, and boost memory skills. They are currently looking for participants who are 50 years or older, speak English, and have mobility difficulties, low income, and sleep problems, as determined by specific survey questions.
If you or a loved one qualify and decide to participate, you can expect to engage in an open trial where the effectiveness of this memory support program will be evaluated. However, certain conditions may exclude individuals from joining, such as severe untreated sleep issues or medical conditions that would make it hard to follow the treatment plan. This trial aims to provide better support for those struggling with sleep and memory, potentially leading to improved quality of life.
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- • 1. Aged 50 years and older;
- • 2. English language fluency;
- • 3. Experiencing a mobility impairment;
- • 4. Low income;
- • 5. Exhibit a sleep or circadian disturbance as determined by endorsing 4 "quite a bit" or 5 "very much" (or the equivalent for reverse scored items) on one or more PROMIS-SD questions.
- • 6. 25-30 on the Montreal Cognitive Assessment, as a negative screen for cognitive impairment.
- • 7. Able/willing to give informed consent.
- Exclusion criteria:
- • 1. Severe untreated sleep disordered breathing (AHI\>30) or moderate untreated sleep disordered breathing with severe daytime sleepiness (AHI of 15-30 and Epworth Sleepiness Scale \>10);
- • 2. Medical conditions that prevent a participant from comprehending and following the basic tenants of treatment (e.g., dementia) or that interfere with sleep in a manner that can't be addressed by a cognitive behavioral treatment (e.g., the Structured Clinical Interview for Sleep Disorders will be used to screen for narcolepsy, REM sleep behavior disorder) or that may preclude full participation (e.g., receipt of end of life care);
- • 3. Homelessness;
- • 4. Night shift work \>2 nights per week in the past 3 months;
- • 5. Substance abuse/dependence only if it makes participation in the study unfeasible;
- • 6. Suicide risk sufficient to preclude treatment on an outpatient basis.
About University Of California, Berkeley
The University of California, Berkeley, a leading research institution renowned for its commitment to scientific innovation and academic excellence, serves as a prominent sponsor of clinical trials aimed at advancing medical knowledge and improving patient outcomes. With a robust infrastructure for interdisciplinary collaboration, UC Berkeley leverages its distinguished faculty, cutting-edge laboratories, and extensive resources to conduct research that addresses critical health challenges. The university is dedicated to fostering a culture of ethical research practices and ensuring the highest standards of safety and efficacy in its clinical investigations, ultimately contributing to the translation of scientific discoveries into tangible health solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Berkeley, California, United States
Patients applied
Trial Officials
Allison Harvey, PhD
Principal Investigator
University of California, Berkeley
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported